Company: NKLR
Filing Date: 2025-07-15
Form Type: S-4/A
Source: 0001213900-25-063846
Chunk: 322

Company: Terra Innovatum Global N.V.
Filing Date: 2025-07-15
Form: S-4/A
Chunk 322
---
 And Micro Nuclear Reactors                                                   |     | 8/25/2024 |     | 8/25/2025   |     | 8/25/2045        |
| Control And Shutdown System For Small And Micro Nuclear Reactors                                                   |     | 1/10/2025 |     | 1/10/2026   |     | 1/10/2046        |
| Small and Micro Nuclear Reactor with Real Time Integrated Safeguard Systems                                        |     | 1/13/2025 |     | 1/13/2026   |     | 1/13/2046        |
| Reactor Vessel Shell And Integrated Radiological Containment For Small And Micro Nuclear Reactors                  |     | 4/20/2025 |     | 4/20/2026   |     | 4/20/2046        |
| Radioisotopes Production with Nuclear Micro-Reactor                                                                |     | 4/20/2025 |     | 4/20/2026   |     | 4/20/2046        |

161 We also engage with international and local regulatory bodies and existing frameworks to safeguard our innovations across various jurisdictions. However, certain countries where our reactor components may be manufactured or where our reactor systems may be deployed may offer less robust protection for nuclear intellectual property compared to the United States or European Union regulatory environments. Our intellectual property strategy employs a systematic assessment framework considering: —Critical component manufacturing locations and supply chain considerations; —Strategic nuclear technology development pathways across different regulatory regimes; —Nuclear -specificintellectual property enforcement mechanisms in target deployment jurisdictions; and —Commercial significance relative to established and emerging competitors in specific nuclear markets and regions. We plan to establish licensing agreements for certain specialized nuclear technologies from third -partydevelopers and anticipate continued expansion of such arrangements as our reactor deployment roadmap advances. Manufacturing and supply chain We implement a fabless and contract manufacturing strategy, and expect to contract with key suppliers for all phases of the manufacturing process. We leverage the expertise of industry -leadingsuppliers that comply with nuclear quality assurance standards — including 10 CFR 50 Appendix B — in areas including fabrication, assembly, quality control, reliability testing, and certification. This approach allows Terra Innovatum to avoid the significant costs and risks associated with owning and operating manufacturing facilities while enabling scalability and rapid response to markets changing conditions. While we plan to directly procure certain critical raw materials used in our products, such as moderators, fuel,